Immunogen (IMGN)
Add to Watchlists Create an AlertImmunogen Enterprise Value:
1.248B for May 22, 2013Immunogen Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 22, 2013 | 1.248B |
| May 21, 2013 | 1.248B |
| May 20, 2013 | 1.233B |
| May 17, 2013 | 1.171B |
| May 16, 2013 | 1.153B |
| May 15, 2013 | 1.182B |
| May 14, 2013 | 1.228B |
| May 13, 2013 | 1.204B |
| May 10, 2013 | 1.157B |
| May 9, 2013 | 1.103B |
| May 8, 2013 | 1.093B |
| May 7, 2013 | 1.123B |
| May 6, 2013 | 1.117B |
| May 3, 2013 | 1.100B |
| May 2, 2013 | 1.102B |
| May 1, 2013 | 1.066B |
| April 30, 2013 | 1.148B |
| April 29, 2013 | 1.149B |
| April 26, 2013 | 1.171B |
| April 25, 2013 | 1.062B |
| April 24, 2013 | 1.044B |
| April 23, 2013 | 1.085B |
| April 22, 2013 | 1.053B |
| April 19, 2013 | 1.060B |
| April 18, 2013 | 997.12M |
| April 17, 2013 | 1.054B |
| April 16, 2013 | 1.092B |
| April 15, 2013 | 1.072B |
| April 12, 2013 | 1.150B |
| April 11, 2013 | 1.295B |
| April 10, 2013 | 1.230B |
| April 9, 2013 | 1.155B |
| April 8, 2013 | 1.161B |
| April 5, 2013 | 1.143B |
| April 4, 2013 | 1.106B |
| April 3, 2013 | 1.072B |
| April 2, 2013 | 1.122B |
| April 1, 2013 | 1.106B |
| March 28, 2013 | 1.142B |
| March 27, 2013 | 1.137B |
| March 26, 2013 | 1.105B |
| March 25, 2013 | 1.126B |
| March 22, 2013 | 1.142B |
| March 21, 2013 | 1.137B |
| March 20, 2013 | 1.163B |
| March 19, 2013 | 1.141B |
| March 18, 2013 | 1.124B |
| March 15, 2013 | 1.137B |
| March 14, 2013 | 1.145B |
| March 13, 2013 | 1.120B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
IMGN Enterprise Value Benchmarks
| Companies | |
|---|---|
| Merrimack Pharmaceuticals | 436.38M |
| Threshold Pharmaceuticals | 211.30M |
| Seattle Genetics | 3.939B |
IMGN Enterprise Value Rankings
| Overall |
75th percentile 1956 of 8005 |
| Sector |
77th percentile 156 of 686 in Healthcare |
| Industry |
87th percentile 32 of 248 in Biotechnology |
IMGN Enterprise Value Range, Past 5 Years
| Minimum | 83.43M | Jun 30 2008 |
| Maximum | 1.295B | Apr 11 2013 |
| Average | 572.83M |
